1Batteux F,Tournear L,Trebeden H.et al.Gene therapy of experimental autoimmune thyroditis by in vivo administration of plasmid DNA coding for Fas ligand[].J Immunol.1999
2Runnic R,Lockwood CJ,Ma Y,et al.Expression of Fas ligand by human cytotrophoblast,implications in placentation and fetal survival[].The Journal of Clinical Endocrinology.1996
3Chervonsky AV,Wang Y,Wong FS,et al.The role of Fas in autoimmune diabetes cell[].The Journal of Clinical Endocrinology.1997
4Mitsiades N,Poulaki V,Kotoula V,et al.Fas/FasL ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto’s thyroiditis[].The Journal of Clinical Endocrinology.1998
5Ramberger AM,Schulte HM,Thuneke I,et al.Expression of the apoptosis-inducing Fas ligand(FasL)in human first and third trimester placenta and choriocarcinoma cells[].The Journal of Clinical Endocrinology.1997
6Stassi G,De Mafia R,Trucco W,et al.Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in IDDM[].The Journal of Experimental Medicine.1997
7Stokes TA,Rymaszewski M,Arscott PL,et al.Constitutive expression of Fas and thyrocytes[].Science.1998
8Fiedler P,Schaetzlein CE,Eibel H.Constitutive expression of Fas and thyrocytes[].Science.1998
